The Shape of the Messenger: Using Protein Structure Information to Design Novel Cytokine-based Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2113-2129
Author(s):
Catherine H. Schein
Therapeutic Enhancement of IL-2 Through Molecular Design
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2171-2183
Author(s):
Delanie J. Cassell, Shurjeel Choudhri, Rachel Humphrey, Robert E. Martell, Theresa Reynolds and Armen B. Shanafelt
Amphiphilic Oligomers: A New Kind of Macromolecular Carrier of Antimitotic Drugs
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
645-665
Author(s):
Christiane Contino-Pepin, Jean Claude Maurizis and Bernard Pucci
Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
683-690
Author(s):
David A. Gewirtz, Mona S. Gupta and Sujatha Sundaram
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
691-714
Author(s):
M. Lopez-Lazaro
Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
Tumor Cell-Based Vaccination in Renal Cell Carcinoma: Rationale,Approaches, and Recent Clinical Development
Journal:
Current Drug Targets
Volume:
3
Page:
401-408
Author(s):
Johannes Volk, Saadettin Sel, Arnold Ganser and Patrick Schoffski
Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Journal:
Current Genomics
Volume:
3
Page:
389-412
Author(s):
M. K. Sauer
Functional Genomics Approaches in Cancer Research
Journal:
Current Genomics
Volume:
3
Page:
425-436
Author(s):
Patrice J. Morin
Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Journal:
Current Drug Metabolism
Volume:
3
Page:
491-525
Author(s):
Consuelo Gajate and Faustino Mollinedo